the levels of cyclophosphamide in samples of urine , serum and cerebrospinal fluid of multiple sclerosis patients , who had received the drug orally ( 4 x 100 mg/day ) have been determined by field desorption mass spectrometry using the principle of stable isotope dilution .
C0010583
cyclophosphamide
C0026769
multiple sclerosis